Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Engelmann, Jan [VerfasserIn]   i
 Murck, Harald [VerfasserIn]   i
 Wagner, Stefanie [VerfasserIn]   i
 Zillich, Lea [VerfasserIn]   i
 Streit, Fabian [VerfasserIn]   i
 Herzog, David P. [VerfasserIn]   i
 Braus, Dieter F. [VerfasserIn]   i
 Tadic, Andre [VerfasserIn]   i
 Lieb, Klaus [VerfasserIn]   i
 Müller, Marianne B. [VerfasserIn]   i
Titel:Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction
Titelzusatz:a post-hoc analysis from the early medication change trial in major depressive disorder : original investigations
Verf.angabe:Jan Engelmann, Harald Murck, Stefanie Wagner, Lea Zillich, Fabian Streit, David P. Herzog, Dieter F. Braus, Andre Tadic, Klaus Lieb and Marianne B. Műller
E-Jahr:2022
Jahr:25 Jan 2022
Umfang:12 S.
Fussnoten:Gesehen am 18.09.2023
Titel Quelle:Enthalten in: The world journal of biological psychiatry
Ort Quelle:Abingdon : Taylor & Francis Group, 2000
Jahr Quelle:2022
Band/Heft Quelle:23(2022), 8, Seite 631-642
ISSN Quelle:1814-1412
Abstract:Objectives Previous studies indicated a relationship between aldosterone, the mineralocorticoid receptor (MR), and antidepressant treatment outcome. Physiological indicators of MR function (blood pressure and electrolytes) are easily accessible and may therefore serve as useful predictors. Thus, our aim was to investigate the predictive value of peripheral MR-related markers for antidepressant treatment outcomes.Methods 826 MDD patients who had participated in the randomised-controlled Early Medication Change (EMC) trial were analysed. Depression severity and MR-related markers were assessed weekly. In 562 patients, genetic variation of five MR-related genes was determined.Results Patients with blood pressure <120mmHg showed higher depression severity (p = 0.005) than patients with blood pressure ≥120mmHg. Patients with a melancholic subtype had significantly lower blood pressures (p = 0.004). Na+/K+ ratio was positively and K+-concentration was negatively correlated to depression severity and to relative changes in HAMD from baseline to day 14, and 56 respectively (p < 0.001). For none of the MR-related genes, genetic variation was associated with treatment outcomes.Conclusions We confirmed early observations of an altered peripheral MR sensitivity, reflected by lower blood pressure, low K+ or high Na+/K+ ratio in patients with more severe depression. These routinely collected biomarkers may potentially be useful for risk stratification in an early stage of treatment. Trial Registration: clinicaltrials.gov Identifier: NCT00974155; https://www.clinicaltrials.gov/ct2/results?term=NCT00974155
DOI:doi:10.1080/15622975.2021.2020334
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1080/15622975.2021.2020334
 Volltext: https://www.tandfonline.com/doi/abs/10.1080/15622975.2021.2020334?journalCode=iwbp20
 DOI: https://doi.org/10.1080/15622975.2021.2020334
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:aldosterone
 biomarker
 Major depressive disorder
 mineralocorticoid receptor
 treatment outcome
K10plus-PPN:185984863X
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69122624   QR-Code
zum Seitenanfang